Prognostic and predictive impact of gene expression in node‐positive early breast cancer patients receiving dose‐dense versus standard‐dose adjuvant chemotherapy

The utility of multigene expression assays in advanced (≥ 4 positive lymph nodes) early breast cancer (EBC) is limited. We conducted exploratory transcriptomic analysis of 758 genes (Breast Cancer 360 panel, nCounter(®) platform; NanoString) in primary tumor samples collected during a phase 3 trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Reinisch, Mattea, Bruzas, Simona, Gluz, Oleg, Ataseven, Beyhan, Schmid, Peter, Cortés, Javier, Blohmer, Jens‐Uwe, Shenoy, Satyendra, Dyson, Mark H., Dittmer‐Grabowski, Christine, Chiari, Ouafaa, Harrach, Hakima, Gebauer, Daniel, Traut, Alexander, Kuemmel, Sherko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257423/
https://www.ncbi.nlm.nih.gov/pubmed/37057719
http://dx.doi.org/10.1002/1878-0261.13435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257423/
https://www.ncbi.nlm.nih.gov/pubmed/37057719
http://dx.doi.org/10.1002/1878-0261.13435

Ejemplares similares